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ABSTRACT: In this paper, we present a deterministic model on the transmission dynamics of Lymphatic Filariasis. 
Non-Standard Finite Difference Method (NSFDM) is employed to attempt the solution of the model. The validity of the 
NSFDM in solving the model is established by using the computer in-built classical fourth-order Runge-Kutta method. The 
comparism between Non-Standard Finite Difference Method solution and Runge-Kutta (RK4) were performed which were 
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Lymphatic filariasis (LF) commonly known as 
elephantiasis is a painful and profoundly disfiguring 
disease that has a major social and economic impact in 
Asia, Africa, the Western pacific and parts of the 
Americas (Ottesen & Ramachandran, 1995). It is one 
of the leading causes of permanent and long-term 
disability in the world (WHO, 1995). About one 
billion people in 80 different countries are known to 
be at risk of this disease (WHO, 2012). Globally, the 
disease is known to affect about 120 million people in 
73 endemic countries, is a debilitating disease, is one 
of the most prevalent and yet one of the most neglected 
tropical diseases with serious economic and social 
consequences (WHO, 1992), (Remme et al., 1993). 
Lymphatic filariasis affects women, men and children 
of all ages. It is a mosquito-borne disease caused by 
tissue dwelling nematodes of Brugia malayi, Brugia 
timori, and Wuchereria bancrofti species (Weil & 
Ramzy, 2007) and is estimated to affect about 120 
million people worldwide with 40 million suffering 
from serious incapacitation and disfigurement and 
1.23 billion people are at risk of infection in 58 
countries worldwide. Currently, one-third of the 
people infected with LF live in India; one-third are in 
Africa and one-third are in South Asia, the Pacific, and 
the Americas (Michael & Bundy, 1997). 
There are so many human problems that can be shown 
as mathematical model in nonlinear ordinary 
differential equations (NL ODEs), such as 
epidemiology problems. SIRS epidemic model is one 
of them which the population have temporary 
immunity to the disease so they can be the susceptible 
population again. SIRS epidemic model can be shown 
as continuous model as a NL ODEs. This continuous 
system has several main properties related to its 
solution and equilibrium point stability. However, the 
exact solution is difficult to be found analytically 
because, as general, NL ODEs has complicated form. 
Therefore, numerical scheme has an important role to 
approximate differential equation solution which is 
difficult to solve analytically. Numerical 
approximation that often used is Euler method and 4th 
order Runge Kutta (RK4). However, on several cases, 
Euler method has disadvantages because the 
discretization model is not dynamically consistence 
with the continuous model. Also, equilibrium stability 
of discrete model of RK4 is restricted to chosen step 
size on its numerical simulation. Therefore, Mickens 
develop non-standard finite difference (NSFD) 
method that, hopefully, obtain scheme which is 
consistent with the continuous model. 
 
MATERIALS AND METHODS 
We develop a mathematical model to study the 
transmission dynamics of Lymphatic Filariasis 
incorporating relevant features such as the classes 
undergoing treatment, vector control (using bed-net 
and insecticide) and drug administration to 
Susceptible class, the infected class with symptoms 
and without symptoms. The Human population of size 
)(tNh  is subdivided based on lymphatic filariasis 
status into the following subpopulations: Susceptible 
human without treatment ( )(1 tS ), Susceptible human 
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undergoing treatment ( )(2 tS ), Infected human but 
not showing signs of elephantiasis  ( )(1 tI ), Infected 
and displaying elephantiasis symptoms ( )(2 tI ) , 
human undergoing treatment from Infected human 
(not showing signs of elephantiasis)( )(1 tT ) and. 
human undergoing treatment from Infected human 
with signs of elephantiasis ( )(2 tT ).Thus, the total 
human population is given by 
 
 
1 2 1 2
1 2
( ) ( ) ( ) ( ) ( )
( ) ( ) (1)
h
N t S t S t I t I t
T t T t
= + + + +
+
   
The mosquito population is divided into the following 
subgroups: non-carrier vector (mosquitoes) ( )(1 tV ) 
and carrier vector (mosquitoes) ( )(2 tV ), so the total 
mosquito population is given by 
 
1 2( ) ( ) ( ) (2)vN t V t V t= +  
 
The mosquitoes and human beings are recruited into 
their susceptible corresponding populations at rates 
vΛ  and hΛ  respectively. Mosquitoes experience 
natural death at a rate vµ and death by insecticide at a 
rate δ  which is proportional to the number in each 
mosquito class. Similarly, human beings experience 
natural death at a rate hµ , which is proportional to the 
number in each human class. 
The mosquito ingests microfilariae when bitting a 
human who is infected with filariasis (elephantiasis 
causing nematodes) at rate vβ , with force of infection 




I t I t
N t
β θ +   
Where, vβ  is the average number of mosquito bites 
which cause transmission of disease from infected 
human to susceptible mosquito and )1,0(∈hθ  
accounts for reduced number of microfilariae in the 
blood stream of individuals infected but not showing 
elephantiasis symptoms. 
Upon getting infected, non-carrier vector (mosquitoes) 
enters the carrier class )(2 tV . Microfilariae pass 
through mosquito gut into hemocoel and develop into 
filariform juveniles. Filariform juveniles escape from 
mosquitoes proboscis when the insect is feeding and 
then penetrate wound structure of a human being at a 
rate hβ  with force of infection 










hβ  is the average number of mosquito bites 
which cause transmission of disease from carrier of 
parasite (mosquito) to susceptible human per 
mosquito. Thus, humans are infected at a rate vβ  
following a bite by mosquito to move into the exposed 
class )(1 tI . Individuals in )(1 tI  progress to the 
stage of showing filariasis symptoms )(2 tI  at rate ρ
. However, some progress to the )(2 tI  as a result of 
secondary infection at a rate vβ . Individuals in 
)(2 tS , classtI −)(1  and classtI −)(2  are 
treated using Diethycarbamzime (DEC) and 
albendazole drugs at a rate  τ   to move into the 
classes undergoing treatment, since recovery from 
filariasis is not permanent. With filariasis, there is no 
disease-induced death. The schematic representation 
of the model is given in figure 1 
 
Fig 1 Schematic Diagram of the Model 
 
Based on the model development description above 
and the schematic diagram in figure 1, the following 
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Table 1: Notation and definition of variables and parameter 
Symbol Description 
)(1 tS  
Susceptible human that are not taking drugs  at time t  
)(2 tS  
Susceptible human undergoing treatment  at time t  
)(1 tI  Infected human but not showing signs of elephantiasis symptoms at time t  
)(2 tI  
Infected human displaying elephantiasis symptoms at time t  
)(1 tT  
Human population undergoing treatment from infected individuals without symptoms at time t  
)(2 tT  
Human population undergoing treatment from infected individuals with signs of elephantiasis at time t  
)(1 tV  
Non-carrier vectors (mosquitoes) at time t  
)(2 tV  
Carrier vectors (mosquitoes) at time t  
)(tNh  
Total human population at time t  
)(tN v  
Total vector population at time t  
hΛ  
Recruitment rate of human population 
vΛ  
Recruitment rate of mosquito population 
hβ  
The rate at which the mosquitoes ingests microfilaria when biting a human who is infected. 
vβ  
The infected rate of human population 
hµ  
Natural death rate for the human population 
vµ  
Natural death rate for the mosquito population 
δ  Vector (mosquitoes) death rate using insecticide 
ρ  Rate of progression of human from )(1 tI -class to )(2 tI -  class. 
θ  Proportion of the susceptible population using mosquito net and Insecticide 
γ  Healing rate or the rate at which those  treated  lose their immunity with time 
τ  Treatment rate for the populations undergoing treatment 
hθ  
This accounts for reduced number of microfilariae in the blood stream of  Individuals infected but not 
showing elephantiasis symptoms 
1ω  Rate at which individuals in )(2 tS  and )(1 tT stop taking drugs 
2ω  Rate at which individuals in  )(2 tT stop taking drugs 
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Positivity of the Solutions: Since the model monitors 
both human and vector population, we need to show 
that all the state variables remain non-negative for all 
times.  
 
Theorem 1: Let then the solutions of 
{ })(),(),(),(),(),(),(),( 21212121 tVtVtTtTtItItStS  
of the system (5) – (12) are positive for all 0≥t  
Proof:  
As applied in Wiah et al. (2014) 
From (5), we have 
1
1









































from (6), we have 
 
 
Similarly, we have 
 
1
2 2( ) (0) 0 (24)
k t
I t I e
−≥ ≥
                                                       
4
1 1( ) (0) 0 (25)
k t
T t T e
−≥ ≥
5
2 2( ) (0) 0 (26)
k t
T t T e
−≥ ≥
                                
6
1 1( ) (0) 0 (27)
k t
V t V e
−≥ ≥
                                
6
2 2( ) (0) 0 (28)
k t
V t V e
−≥ ≥
Hence, the solutions of 
{ })(),1(),(),(),(),(),(),1( 21212121 tVVtTtTtItItSS
 of the system (5) – (12) are positive for all 0≥t  
 
Non-Standard Finite Difference Method: The 
solutions of the finite difference scheme. For the 
construction of the numerical scheme, discretizations 
of the system of equations are made based on the 
approximations of temporal derivatives by a 
generalized forward scheme of first order. Hence, if 
( ) ( )RCtf ′∈ , let us define its derivative as follows; 
( ) ( ) ( )
( )
( )( ) , 0
d f t f t h f t




   (29) 
Where ( )hG  is a real-valued function on R . In our 
work, we will also make use of denominator functions 
which are little complex function of the time step size 
than the classical one  
We apply Micken’s scheme by replacing the step-size 
h  by functions ( ) 10.,..,2,1, =ihGi  and use non-
local approximation for the non-linear terms. Let us 
discretize the system of equations (5) – (12) and 
change the NSFD scheme to explicit form as follows; 
 
( )
( ) ( ) ( ) ( ) ( )[ ]
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are the denominator functions. With the initial conditions 
 
( ) ( )
( ) ( )
( ) ( )





0 100,00,000 , 0 30,000,000 ,
0 12,000,000 , 0 6,840,000 ,
0 8,000,000 , 0 6,000,000 ,










And the parameter values are; 
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1
2
177,155,754 , 2,960,000,000 ,
0.0189 , 0.00013 ,
3,348, 245 , 384,800 ,
0.009926 , 0.000249 ,
0.00002797 , 0.0017 ,
0.25 , 0.25 ,

























for   
3,2,1,0=k
 
The computation of equations above was done using maple 2017 software 
 
RESULTS AND DISCUSSION 
We present the numerical simulation which 
demonstrates the analytical results for the proposed 
Lymphatic Filariasis (Elephantiasis) model. This is 
achieved by using some set of parameter values given 
above and whose source are mainly from literature and 
well as assumptions. The NSFDM is demonstrated 
against mapple in-buit fourth order Runge-Kutta 
Procedure for the solution of the model. Figure 2 to 
Figure 5 shows the combined plots of the solutions of 
)(1 tS , )(2 tS , )(1 tI  , )(2 tI , )(1 tT , )(2 tT , 
)(1 tV and )(2 tV  by NSFD and RK4. 
The graphical representations are from the analytical 
solutions of the model equations. They are plotted 
using MAPLE software. 
   
Fig 2: Comparison Solution of Susceptible population without 




Fig 3: Comparison Solution of Susceptible Population receiving 
treatment by NSFD and RK4 
 
   
 Fig 4: Comparison Solution of Infected Population without 
symptom by NSFD and RK4 
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Fig 5: Comparison Solution of Infected Population with symptom 
by NSFD and RK4 
 
Figure 2 to Figure 5 shows some of the combined plots 
of the solutions of 
)(1 tS , )(2 tS , )(1 tI  , )(2 tI ,
)(1 tT , )(2 tT , )(1 tV and )(2 tV  by NSFD and 
RK4. The solutions obtained by using Non-Standard 
Finite Difference Method with given initial conditions 
compared favorably with the solution obtained by 
using classical fourth-other Runge-Kuta method. The 
solutions of the two methods from our analysis follows 
the same pattern and behavior. This shows that Non-
Standard Finite Difference Method is suitable and 
efficient to conduct the analysis of Lymphatic 
Filariasis model. 
 
Conclusion: Non-Standard Finite Difference Method 
(NSFDM) has been successfully applied to solve for 
the solution of the Elephantiasis Model with given 
initial conditions. This method provides an explicit 
solution which is very useful for understanding and 
analyzing an epidemic model. Numerical simulations 
were carried out to compare the results obtained by 
Non-Standard Finite Difference Method with the 
classical fourth-order Runge-Kutta method. It can be 
concluded that this method is very powerful and 
efficient in obtaining numerical solutions for the 
analysis of modern epidemics. 
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